Home

ARNOLD J LEVINE

CIK 1124164 · last filed 2026-06-05

ARNOLD J LEVINE is a corporate insider who has filed 47 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for PMVP, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$1.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $600.9K across reported positions. 17 SEC filings were submitted jointly with Innoviva, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$600.9K

Companies

6

Total Filings

47

Lifetime Open-Market Net

-$1.47M

Filer Profile

Reported Address
C/O JAN STERN REED BAXTER INTERNATIONAL
ONE BAXTER PARKWAY DF2 2W
DEERFIELD, IL 60015
Related Filers
Innoviva, Inc. — 17 joint filings, latest 2014-03-25
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PMVP Director 409,842 $1.35 $555.3K -$568.3K 11 2026-06-05
MGTX Director — $13.53 — $0 4 2022-06-09
Innoviva, Inc. (THRX) Delisted Director 111,794 $4.06 $453.9K $0 11 2014-03-25
LIFE Director 1,122 $40.63 $45.6K -$902.0K 10 2013-04-26
INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Director 15,287 $0.04 $683 $0 5 2011-05-19
APPLIED BIOSYSTEMS INC. (CRA) Delisted Director 29,464 — — $0 5 2007-12-05

Recent Filings

47 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-05 PMVP Grant (A) — $0 EDGAR
2025-06-09 PMVP Grant (A) — $0 EDGAR
2024-06-10 PMVP Grant (A) — $0 EDGAR
2023-06-12 PMVP Grant (A) — $0 EDGAR
2022-06-09 MGTX Grant (A) — $0 EDGAR
2022-06-06 PMVP Grant (A) — $0 EDGAR
2021-09-23 PMVP Sell (S) −3,500 -$105.0K EDGAR
2021-08-24 PMVP Sell (S) −3,500 -$103.2K EDGAR
2021-07-22 PMVP Mixed −3,500 -$122.9K EDGAR
2021-06-22 PMVP Sell (S) −3,500 -$116.4K EDGAR
Showing 1–10 of 47
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.